Like Professor X and Magneto, Intel and AMD know when to team up and take on a shared adversary. The two companies have formed a new x86 advisory group to stem the platform’s bleeding from Arm ...

Stem cell therapy still has many hurdles to clear before becoming a viable therapeutic option for age-related macular degeneration, but it may have the potential to transform treatment in the ...

AMD remains deeply committed to fostering STEM education and preparing the next generation of innovators. Not only did 2,500+ students experience STEM activities in a meaningful and inspiring way, but ...

AMD recently partnered with professional soccer team Austin FC, EK Fluid Gaming and two educational organizations to welcome more than 100 students and educational staff for a hands-on day of science, ...

This can lead to impaired vision, photoreceptor loss, and even blindness in patients with AMD. However, recent research into stem cell patches has shown the potential to restore the structure and ...

Stem Cell Therapy for AMD Appears Beneficial but Risky. March 16, 2017 (HealthDay News) — Stem cells may offer new hope for patients with age-related macular degeneration, but that promise ...

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

Shares of StemCells (STEM +22.9%) jump on heavy volume in response to its announcement of positive interim results from the Phase 1/2 clinical trial of its HuCNS-SC human neural stem cell platform ...